activities of competitors

the prolonged silence of Neuren is interposed with the evident opening of direct competitors such as Anavex; the recent increases in the latter's market validate relevant initiatives such as new directors of thickness and participation in international conferences with the intent to clearly show updates on their potential.
as a result we register a downsizing of interest on Neuren; I believe that, as never before, the company must emerge from ambiguity and update the market on developments announced in recent months. The words of Treagus were too clear and clear in the last update to shareholders regarding a turn towards a partnership not to invite him to start putting the cards on the table; the first natural passage is the announcement of a phase 3 opening which effectively converts the options of Treagus and other executives into ordinary shares; in succession to the assigned assignment, it seems logical and opportunistic for them to announce something really substantial for the good of themselves and those who are members like us.
this is what Anavex is doing recently:

https://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=267891

https://www.nasdaq.com/press-releas...nt-team-and-board-of-directors-20180305-00316

https://finance.google.com/finance?q=NASDAQ:AVXL&ei=AMCfWoHhM5KWsQG_q5KwBw